Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lyophilization and development of solid protein pharmaceuticals.

W Wang1

  • 1Biotechnology, Bayer Corporation, 800 Dwight Way, Berkeley, CA 94701, USA. wei.wang.b@bayer.com

International Journal of Pharmaceutics
|September 1, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional nucleotide excision repair is required for the preferential removal of N-ethylpurines from the transcribed strand of the dihydrofolate reductase gene of Chinese hamster ovary cells.

Molecular and cellular biology·1997
Same author

Long-term expression of Fos-related antigen and transient expression of delta FosB associated with seizures in the rat hippocampus and striatum.

Journal of neurochemistry·1997
Same author

Mechanical strain-induced proliferation of osteoblastic cells parallels increased TGF-beta 1 mRNA.

Biochemical and biophysical research communications·1996
Same author

Regulation of endothelin-1 expression in the bovine corpus luteum: elevation by prostaglandin F 2 alpha.

Endocrinology·1996
Same author

Effect of angiotensin II on the apical K+ channel in the thick ascending limb of the rat kidney.

The Journal of general physiology·1996
Same author

A deep-tissue hemangioma presenting as a rapidly progressive expanding mass and thrombocytopenia in an infant.

Pediatric emergency care·1996

Lyophilization (freeze-drying) is crucial for stabilizing protein pharmaceuticals but causes denaturation. This review covers recent advances in understanding and mitigating these stresses for improved solid-state protein formulation.

Area of Science:

  • Biopharmaceutical Formulation
  • Protein Stabilization Technologies
  • Lyophilization Science

Background:

  • Recombinant protein pharmaceuticals face challenges due to production complexity and inherent protein instability.
  • Solid-state formulation, primarily via lyophilization (freeze-drying), is essential for achieving adequate shelf-life.
  • Lyophilization induces stresses that can lead to protein denaturation, impacting product efficacy and stability.

Purpose of the Study:

  • To provide an updated perspective on lyophilization processes for solid protein pharmaceuticals.
  • To review recent advancements in understanding and addressing protein instability during lyophilization and storage.
  • To highlight strategies for cryo- and lyoprotection, lyophilization cycle design, and formulation development.

Main Methods:

Related Experiment Videos

  • Review of recent scientific literature (past 10 years) on protein lyophilization and stabilization.
  • Analysis of denaturation stresses inherent to freezing and drying processes.
  • Examination of excipient roles in cryo- and lyoprotection.
  • Discussion on robust lyophilization cycle design and solid-state formulation strategies.

Main Results:

  • Identified critical issues related to protein instability during lyophilization and long-term storage.
  • Highlighted the importance of protein stabilizers (excipients) in mitigating denaturation stresses.
  • Emphasized the need for optimized lyophilization cycles tailored to specific protein formulations.

Conclusions:

  • Despite advancements, achieving long-term stability for solid protein pharmaceuticals remains a significant challenge.
  • Continued research into lyophilization stresses, protective excipients, and cycle optimization is vital.
  • Effective formulation strategies are key to overcoming instability and ensuring the quality of protein-based drugs.